ENG/中
老虎證券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
巨子生物
80.500
+0.500
0.63%
手動刷新
成交量:
158.95萬
成交額:
1.28億
市值:
862.16億
市盈率:
35.73
高:
81.200
開:
79.100
低:
79.100
收:
80.000
資料載入中...
總覽
公司
新聞
公告
《大行》摩通列出MSCI中國指數各板塊成份股今年以來獲上調盈測較多的股份(表)
阿斯达克财经
·
04-15
鉅子生物盤中異動 股價大漲5.00%
市场透视
·
04-15
鉅子生物大漲近10%創新高,膠原蛋白未來可期?
财华社
·
04-14
港股異動 | 鉅子生物(02367)漲超10%創新高 公司聲明可復美產品未添加EGF 大單品驅動收入利潤高增
智通财经
·
04-14
可復美被質疑產品添加EGF,凌晨回應“未添加”,該品牌去年營收45億元
红星新闻
·
04-14
港股異動 | 零售股走勢強勁 多點數智(02586)漲超20% 機構建議關注內需提振下投資機遇
智通财经
·
04-14
鉅子生物稱可復美產品未添加人表皮生長因子
中新经纬
·
04-12
華熙的玻尿酸王者地位,正在被膠原蛋白反攻
华尔街见闻
·
04-12
突然暴漲18%!原因來了
市场资讯
·
04-10
鉅子生物04月09日主力淨流入1972萬元 散户資金拋售
市场透视
·
04-09
鉅子生物2024年淨利增長42%,線上渠道增長顯着
群益证券
·
04-09
業績大漲背後 鉅子生物的“財富密碼”可持續嗎?
中国商报网
·
04-09
鉅子生物盤中異動 大幅下挫5.89%
市场透视
·
04-09
瑞銀:降鉅子生物(02367)目標價至80.6港元 維持“買入”評級
智通财经
·
04-08
《大行》瑞銀:鉅子生物(02367.HK)上財年利潤率略遜預期 降目標價至80.6元
阿斯达克财经
·
04-08
鉅子生物盤中異動 早盤股價大漲6.49%報64.850港元
市场透视
·
04-08
鉅子生物04月07日遭主力拋售1467萬元
市场透视
·
04-07
招銀國際:內地醫藥行業有望在2025年繼續迎來估值修復
智通财经
·
04-07
鉅子生物:可復美延續高增長 可麗金提速 膠原龍頭潛力可期
中泰证券
·
04-07
點評 | 鉅子生物:膠原棒勢能超預期,可麗金線上高增拉動環比加速,關注新品迭代&醫美獲批增量
刘章明消费产业...
·
04-06
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02367/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02367","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02367\",,,,,undefined,":{"symbol":"02367","market":"HK","secType":"STK","nameCN":"巨子生物","latestPrice":80.5,"timestamp":1746173305030,"preClose":80,"halted":0,"volume":1589493,"delay":0,"floatShares":1071000000,"shares":1071000000,"eps":2.2528412067116173,"marketStatus":"休市中","change":0.5,"latestTime":"05-02 16:08:25","open":79.1,"high":81.2,"low":79.1,"amount":127954799,"amplitude":0.02625,"askPrice":80.5,"askSize":11600,"bidPrice":80.35,"bidSize":800,"shortable":3,"etf":0,"ttmEps":2.2095616647446326,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1746495000000},"marketStatusCode":7,"adr":0,"listingDate":1667491200000,"exchange":"SEHK","adjPreClose":80,"dividendRate":0.01205,"openAndCloseTimeList":[[1746149400000,1746158400000],[1746162000000,1746172800000]],"volumeRatio":0.252873,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02367\",,,,,undefined,":{"symbol":"02367","floatShares":1071000000,"roa":"21.92%","roe":"35.88%","lyrEps":2.252841,"volumeRatio":0.252873,"shares":1071000000,"dividePrice":0.97,"high":81.2,"amplitude":0.02625,"preClose":80,"low":79.1,"week52Low":35,"pbRate":"11.31","psRate":"14.51","week52High":81.8,"institutionHeld":0,"latestPrice":80.5,"committee":-0.870968,"eps":2.2528412067116173,"divideRate":0.01205,"volume":1589493,"delay":0,"ttmEps":2.2095616647446326,"open":79.1,"prevYearClose":49.9,"prevWeekClose":77.1,"prevMonthClose":80,"prevQuarterClose":70.45,"fiveDayClose":77.95,"twentyDayClose":70.45,"sixtyDayClose":56.85},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02367\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2527435223","title":"《大行》摩通列出MSCI中國指數各板塊成份股今年以來獲上調盈測較多的股份(表)","url":"https://stock-news.laohu8.com/highlight/detail?id=2527435223","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527435223?lang=zh_tw&edition=fundamental","pubTime":"2025-04-15 11:49","pubTimestamp":1744688940,"startTime":"0","endTime":"0","summary":"沽空资料截至 2025-04-15 12:25。) (美股为即时串流报价; OTC市场股票除外,资料延迟最少15分钟。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112152951051_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112152951051_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/analysis/china-hot-topic-content.aspx?id=NOW.1433910&catg=4&source=AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["600115","02611","01801","300033","601872","03323","02367","000301","09926","00322","00175","300999","601991","01209","600415","000783","00270","600010","00136","01818","600061","601111","300476","600111","601699","688728","600642","600023","GELYY","00268","600968","601555","600066","002074","09626","03888","603392","605499","80175","688256","688047","600418","EVS.SI","01519","002128","600900","000729","03692","09992"],"gpt_icon":1},{"id":"2527108231","title":"鉅子生物盤中異動 股價大漲5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527108231","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527108231?lang=zh_tw&edition=fundamental","pubTime":"2025-04-15 09:47","pubTimestamp":1744681678,"startTime":"0","endTime":"0","summary":"2025年04月15日早盘09时47分,巨子生物股票出现波动,股价大幅上涨5.00%。截至发稿,该股报79.800港元/股,成交量215.79万股,换手率0.21%,振幅4.21%。巨子生物股票所在的生物技术行业中,整体涨幅为2.51%。其相关个股中,映恩生物-B、歌礼制药-B、巨子生物涨幅较大,振幅较大的相关个股有映恩生物-B、科伦博泰生物-B、和誉-B,振幅分别为39.11%、13.40%、6.53%。2022年,巨子生物登陆港交所,成为“重组胶原蛋白第一股”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415094759a45923cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415094759a45923cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999004311.SGD","LU2488822045.USD","BK1207","02367"],"gpt_icon":0},{"id":"2527154552","title":"鉅子生物大漲近10%創新高,膠原蛋白未來可期?","url":"https://stock-news.laohu8.com/highlight/detail?id=2527154552","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527154552?lang=zh_tw&edition=fundamental","pubTime":"2025-04-14 18:53","pubTimestamp":1744627996,"startTime":"0","endTime":"0","summary":"4月14日,港股的“重组胶原蛋白第一股”巨子生物(02367.HK)大涨9.83%,创下上市以来的新高,目前公司报76港元/股,市值787.3亿港元。","market":"us","thumbnail":"https://images.finet.hk/photoLib/title/202504_1/3fa7651a-0e70-40a9-b726-a6a627fc5f50.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202504_1/3fa7651a-0e70-40a9-b726-a6a627fc5f50.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/67fce91c2308295289d7e0a9","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["LU2488822045.USD","02367","BK1207","SG9999004311.SGD"],"gpt_icon":0},{"id":"2527897290","title":"港股異動 | 鉅子生物(02367)漲超10%創新高 公司聲明可復美產品未添加EGF 大單品驅動收入利潤高增","url":"https://stock-news.laohu8.com/highlight/detail?id=2527897290","media":"智通财经","labels":["dataReport","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527897290?lang=zh_tw&edition=fundamental","pubTime":"2025-04-14 14:37","pubTimestamp":1744612639,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,巨子生物盘中涨超10%,高见76.35港元创上市新高。4月12日凌晨,可复美在官方微博发布《致广大可复美消费者的一封信》,明确表示其旗下所有产品均未添加人表皮生长因子。财报显示,2024年,可复美单一品牌为巨子生物贡献八成营收,约为45亿元。因此,净利润率跌4个百分点至37.2%。该行相信,巨子生物产品组合成功扩展有助推动其长期快速增长,另外,四种注射产品目前正处于申请阶段,并即将商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1278041.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2488822045.USD","SG9999004311.SGD","BK1207","02367","EGF"],"gpt_icon":0},{"id":"2527977327","title":"可復美被質疑產品添加EGF,凌晨回應“未添加”,該品牌去年營收45億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527977327","media":"红星新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527977327?lang=zh_tw&edition=fundamental","pubTime":"2025-04-14 12:27","pubTimestamp":1744604820,"startTime":"0","endTime":"0","summary":"近日,有消费者向媒体控诉可复美在一款产品中添加了表皮生长因子,4月12日凌晨,可复美在官方微博发布《致广大可复美消费者的一封信》,明确表示其旗下所有产品均未添加人表皮生长因子。财报显示,2024年,可复美单一品牌为巨子生物贡献了八成左右的营收,约为45亿元。其中,可复美品牌在2024年的销售收入达到45.42亿元,同比增长约62.9%,占巨子生物总营收的82%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041413120494d4a1a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041413120494d4a1a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02367"],"gpt_icon":0},{"id":"2527750923","title":"港股異動 | 零售股走勢強勁 多點數智(02586)漲超20% 機構建議關注內需提振下投資機遇","url":"https://stock-news.laohu8.com/highlight/detail?id=2527750923","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527750923?lang=zh_tw&edition=fundamental","pubTime":"2025-04-14 11:13","pubTimestamp":1744600392,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,零售股走势强劲,截至发稿,多点数智涨19.4%,报11.14港元;老铺黄金涨10.36%,报820港元;上美股份涨6.6%,报53.3港元;巨子生物涨7.08%,报74.1港元;泡泡玛特涨6.49%,报159.2港元;蜜雪集团涨4.34%,报437.2港元。消息面上,国信证券表示,国内政策和流动性宽松有望带动内需板块整体走势相对偏强。美容护理板块整体有望进一步受益国货替代加速,同时产品创新升级有望带来个股机遇。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1277971.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1207","02145","BK1544","SG9999002950.SGD","LU0348767384.USD","BK1224","BK1109","LU0823426308.USD","BK1616","LU2488822045.USD","02367","LU0348766576.USD","LU0823426480.USD","BK1233","BK1227","SG9999004311.SGD","02586"],"gpt_icon":1},{"id":"2527093025","title":"鉅子生物稱可復美產品未添加人表皮生長因子","url":"https://stock-news.laohu8.com/highlight/detail?id=2527093025","media":"中新经纬","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527093025?lang=zh_tw&edition=fundamental","pubTime":"2025-04-12 17:52","pubTimestamp":1744451561,"startTime":"0","endTime":"0","summary":"中新经纬4月12日电 巨子生物表示,可复美产品未添加人表皮生长因子。秦女士曾自费将该产品送检,该款产品中检测出了其在产品说明书中并没有标注的成分:人表皮生长因子。大象新闻购买了秦女士使用的同款可复美产品送到第三方检测公司鉴定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041310244697365201&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041310244697365201&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","02367","SG9999004311.SGD","LU2488822045.USD"],"gpt_icon":0},{"id":"2526674176","title":"華熙的玻尿酸王者地位,正在被膠原蛋白反攻","url":"https://stock-news.laohu8.com/highlight/detail?id=2526674176","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526674176?lang=zh_tw&edition=fundamental","pubTime":"2025-04-12 13:39","pubTimestamp":1744436396,"startTime":"0","endTime":"0","summary":"打不过就加入","market":"us","thumbnail":"https://wpimg-wscn.awtmt.com/b8090aa4-cc4c-475a-9867-2c23f1fb40c4.jpeg","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/b8090aa4-cc4c-475a-9867-2c23f1fb40c4.jpeg"],"rights":{"source":"wallstreetcn_hot_news","url":"https://wallstreetcn.com/articles/3745083","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3745083","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"wallstreetcn_hot_news","symbols":["BK1207","02367","LU2488822045.USD","SG9999004311.SGD"],"gpt_icon":0},{"id":"2526561640","title":"突然暴漲18%!原因來了","url":"https://stock-news.laohu8.com/highlight/detail?id=2526561640","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526561640?lang=zh_tw&edition=fundamental","pubTime":"2025-04-10 20:47","pubTimestamp":1744289220,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 北交所“市值第一股”锦波生物自主研发生产的第三个采用生物新型材料——重组人源化胶原蛋白制备的三类植入医疗器械,近日正式获批。 4月10日,锦波生物股价震荡上涨,最终以348.86元收盘,再创历史新高;收盘涨幅为17.87%,最新市值为309亿元。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2025-04-10/doc-inessues2295915.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1207","LU2488822045.USD","02367","SG9999004311.SGD"],"gpt_icon":0},{"id":"2526323173","title":"鉅子生物04月09日主力淨流入1972萬元 散户資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2526323173","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526323173?lang=zh_tw&edition=fundamental","pubTime":"2025-04-09 16:16","pubTimestamp":1744186605,"startTime":"0","endTime":"0","summary":"04月09日, 巨子生物股价涨5.04%,报收67.75元,成交金额3.89亿元,换手率0.57%,振幅11.94%,量比1.11。巨子生物今日主力资金净流入1972万元,上一交易日主力净流出3669万元。该股近5个交易日下跌5.61%,主力资金累计净流出3805万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流出7242万元,其中净流出天数为12日。该股主力净额占比0.03%,港股市场排名261/2652。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409170946a6b53a62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409170946a6b53a62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","LU2488822045.USD","SG9999004311.SGD","02367"],"gpt_icon":0},{"id":"2526766330","title":"鉅子生物2024年淨利增長42%,線上渠道增長顯着","url":"https://stock-news.laohu8.com/highlight/detail?id=2526766330","media":"群益证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526766330?lang=zh_tw&edition=fundamental","pubTime":"2025-04-09 16:15","pubTimestamp":1744186524,"startTime":"0","endTime":"0","summary":"HK)在2024年表现出色,实现营收55.4亿元人民币,同比增长57.2%,归母净利润达21.5亿元人民币,同比增长42.1%。经调整利润为21.5亿元人民币,同比增长46.5%,符合市场预期。此外,公司拟派发每股0.6021元人民币的股息及特别股息0.5921元人民币,以当前股价计算,股息率约为2.1%。其中,“可复美”品牌收入达45.4亿元人民币,同比增长62.9%,主要得益于线上渠道的高速增长。2024年销售费用率为36.3%,同比增加3.2个百分点,研发费用率则保持稳定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409165318a453841c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409165318a453841c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","02367","LU2488822045.USD","SG9999004311.SGD"],"gpt_icon":0},{"id":"2526870909","title":"業績大漲背後 鉅子生物的“財富密碼”可持續嗎?","url":"https://stock-news.laohu8.com/highlight/detail?id=2526870909","media":"中国商报网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526870909?lang=zh_tw&edition=fundamental","pubTime":"2025-04-09 10:17","pubTimestamp":1744165043,"startTime":"0","endTime":"0","summary":"不过,仍有市场声音认为,重组胶原蛋白一直是巨子生物的“财富密码”,但是其已上市的化妆品技术门槛低、同质化竞争严重。业绩大涨仍存隐忧根据巨子生物发布的财报,2024年,巨子生物营收达55.39亿元,同比增长57.2%;净利润达20.62亿元,同比增长42.1%。国家药监局官网显示,目前,巨子生物注册备案的均是敷料类产品。此外,巨子生物超八成的收入来自以重组胶原蛋白为基础的护肤品牌可复美。也有投资机构上调了巨子生物的目标价。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040910181094d03bea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040910181094d03bea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02367","SG9999004311.SGD","LU2488822045.USD","BK1207"],"gpt_icon":0},{"id":"2526874857","title":"鉅子生物盤中異動 大幅下挫5.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526874857","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526874857?lang=zh_tw&edition=fundamental","pubTime":"2025-04-09 09:30","pubTimestamp":1744162222,"startTime":"0","endTime":"0","summary":"2025年04月09日早盘09时30分,巨子生物股票出现异动,股价大幅下挫5.89%。截至发稿,该股报60.700港元/股,成交量4.72万股,换手率0.00%,振幅2.87%。巨子生物股票所在的生物技术行业中,整体跌幅为2.93%。其相关个股中,云康集团、华康生物医学、中生北控生物科技涨幅较大,振幅较大的相关个股有科伦博泰生物-B、泰格医药、同源康医药-B,振幅分别为7.87%、6.76%、6.04%。但巨子生物却继续高增,不仅营收突破50亿元,同比增速更是达到57.2%,为5年来新高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409093024a4531973&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409093024a4531973&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02367","LU2488822045.USD","SG9999004311.SGD","BK1207"],"gpt_icon":0},{"id":"2525340908","title":"瑞銀:降鉅子生物(02367)目標價至80.6港元 維持“買入”評級","url":"https://stock-news.laohu8.com/highlight/detail?id=2525340908","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525340908?lang=zh_tw&edition=fundamental","pubTime":"2025-04-08 14:16","pubTimestamp":1744093009,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,瑞银发布研报称,巨子生物(02367)2024财年业绩与该行预测基本一致,惟利润率略低于预期。瑞银表示,对巨子生物销售增长保持乐观,但在经营环境挑战及产品或渠道组合转变下,对公司利润率表现转为更保守。该行将巨子生物目标价由82港元下调至80.6港元,并认为该股具有上升潜力,主要考虑到其2024至2026财年销售及盈利复合年均增长率预计分别为32%及22%,维持“买入”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1275269.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02367"],"gpt_icon":0},{"id":"2525783179","title":"《大行》瑞銀:鉅子生物(02367.HK)上財年利潤率略遜預期 降目標價至80.6元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525783179","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525783179?lang=zh_tw&edition=fundamental","pubTime":"2025-04-08 14:02","pubTimestamp":1744092120,"startTime":"0","endTime":"0","summary":"瑞银发表研报指,巨子生物(02367.HK) 2024财年业绩与该行预测基本一致,惟利润率略低于预期。瑞银表示,对巨子生物销售增长保持乐观,但在经营环境挑战及产品或渠道组合转变下,对公司利润率表现转为更保守。该行将巨子生物目标价由82元下调至80.6元,并认为该股具有上升潜力,主要考虑到其2024至2026财年销售及盈利复合年均增长率预计分别为32%及22%,维持“买入”评级。(js/w)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20221209170600934_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20221209170600934_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1432332/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02367"],"gpt_icon":0},{"id":"2525181000","title":"鉅子生物盤中異動 早盤股價大漲6.49%報64.850港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525181000","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525181000?lang=zh_tw&edition=fundamental","pubTime":"2025-04-08 09:30","pubTimestamp":1744075810,"startTime":"0","endTime":"0","summary":"2025年04月08日早盘09时30分,巨子生物股票出现波动,股价快速拉升6.49%。截至发稿,该股报64.850港元/股,成交量1.98万股,换手率0.00%,振幅5.25%。资金方面,该股资金流入13.961万港元,流出6.192万港元。巨子生物股票所在的生物技术行业中,整体涨幅为1.74%。其相关个股中,来凯医药-B、加科思-B、腾盛博药-B涨幅较大,振幅较大的相关个股有来凯医药-B、腾盛博药-B、巨子生物,振幅分别为8.57%、6.33%、5.25%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040809301297314587&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040809301297314587&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02367","SG9999004311.SGD","LU2488822045.USD","BK1207"],"gpt_icon":0},{"id":"2525945100","title":"鉅子生物04月07日遭主力拋售1467萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525945100","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525945100?lang=zh_tw&edition=fundamental","pubTime":"2025-04-07 16:17","pubTimestamp":1744013840,"startTime":"0","endTime":"0","summary":"04月07日, 巨子生物股价跌14.71%,报收60.90元,成交金额4.10亿元,换手率0.63%,振幅10.08%,量比1.41。巨子生物今日主力资金净流出1467万元,连续4日净流出,上一交易日主力净流出292万元。该股近5个交易日下跌11.54%,主力资金累计净流出347万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流出1038万元,其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407171331a6b270f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407171331a6b270f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999004311.SGD","LU2488822045.USD","02367","BK1207"],"gpt_icon":0},{"id":"2525691330","title":"招銀國際:內地醫藥行業有望在2025年繼續迎來估值修復","url":"https://stock-news.laohu8.com/highlight/detail?id=2525691330","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525691330?lang=zh_tw&edition=fundamental","pubTime":"2025-04-07 14:42","pubTimestamp":1744008148,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,招银国际发布研报称,受益于国内药品价格政策优化、国内宏观环境改善,以及创新药和器械出海持续增长,内地医药行业有望在2025年继续迎来估值修复。丙类医保目录年内即将落地,创新药将获得更好的支付环境。医疗设备招标加速复苏,将推动国产医疗设备企业盈利复苏。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1274534.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02359","LU0196878994.USD","LU0588546209.SGD","LU2488822045.USD","BK1583","06160","LU2125910500.SGD","LU2328871848.SGD","LU1046422090.SGD","LU2045819591.USD","LU0052750758.USD","LU1969619763.USD","02367","06990","BK1500","BK1593","LU0320764599.SGD","BK1576","01530","BK1207","SG9999004311.SGD","BK1141","LU0307460666.USD","BK1161","LU0708995583.HKD","LU2242644610.SGD","01801","BK1589","BK1588"],"gpt_icon":0},{"id":"2525050523","title":"鉅子生物:可復美延續高增長 可麗金提速 膠原龍頭潛力可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2525050523","media":"中泰证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525050523?lang=zh_tw&edition=fundamental","pubTime":"2025-04-07 00:00","pubTimestamp":1743955200,"startTime":"0","endTime":"0","summary":"巨子生物发布24 年财务报告:1)2024 年:公司24 年营业收入55.4 亿元,YOY+57%;经调整净利润21.5 亿元,YOY+46.5%。收入拆分:可复美维持高增长,可丽金24H2 提速。其中,可复美、可丽金24 下半年收入分别为24.7 亿元和4.4 亿元,YOY 分别增长58.4%以及50.1%。新品焦点面霜通过3R 光奕律时修护体系实现精准人群触达,双十一期间跻身天猫修复面霜国货TOP2 及抖音胶原蛋白霜好评榜TOP1,大单品潜力逐步显现。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407131625a4506171&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407131625a4506171&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK1207","02367","SG9999004311.SGD"],"gpt_icon":0},{"id":"2525709905","title":"點評 | 鉅子生物:膠原棒勢能超預期,可麗金線上高增拉動環比加速,關注新品迭代&醫美獲批增量","url":"https://stock-news.laohu8.com/highlight/detail?id=2525709905","media":"刘章明消费产业...","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525709905?lang=zh_tw&edition=fundamental","pubTime":"2025-04-06 23:15","pubTimestamp":1743952531,"startTime":"0","endTime":"0","summary":"本文来自方正证券研究所《巨子生物公司点评报告:胶原棒势能超预期,可丽金线上高增拉动环比加速,关注新品迭代&医美获批增量》,欲了解报告详情,请阅读报告原文。收入拆分:双品牌多渠道高增,25Q1势能延续按品牌:可复美胶原棒势能超预期,焦点稳步拓展放量,可丽金线上驱动增长加速。③可丽金增长超预期,线上高速增长有望拉动整体增长加速。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407020205a44fdb25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407020205a44fdb25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","SG9999004311.SGD","BK1207","02367"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02367\",params:#limit:5,,,undefined,":[{"date":"2025-06-17","symbol":"02367","amount":0.5921,"announcedDate":"2025-03-26","type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2025-06-18","defaultRemindTime":1750123800000,"name":"巨子生物","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-29","payableDate":"2025-06-18","currency":"CNY","dateTimestamp":1750089600000,"payDate":"2025-08-29"},{"date":"2025-03-26","symbol":"02367","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742952600000,"name":null,"time":"盤後","dateTimestamp":1742918400000,"actualEps":null},{"date":"2024-08-19","symbol":"02367","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724031000000,"name":null,"time":"盤後","dateTimestamp":1723996800000,"actualEps":null},{"date":"2024-06-17","symbol":"02367","amount":0.97,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2024-06-18","defaultRemindTime":1718587800000,"name":"巨子生物","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-05","payableDate":"2024-06-18","currency":"HKD","dateTimestamp":1718553600000,"payDate":"2024-07-05"},{"date":"2024-03-25","symbol":"02367","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02367\",market:\"HK\",,,undefined,":[{"executeDate":"2024-06-17","recordDate":"2024-06-18","paymentDate":"2024-07-05","value":0.97,"currency":"HKD"},{"executeDate":"2025-06-17","recordDate":"2025-06-18","paymentDate":"2025-08-29","value":0.5921,"currency":"CNY"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02367\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.4737,"buy":0.5263,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5263,"analysts":19,"updateTime":1745424000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02367\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02367","date":"2025-04-30","current":37.231772,"percent":0.881384,"low":18.546195,"twenty":25.868985,"median":29.344363,"eighty":34.133202,"high":60.214956,"avg":30.50703,"sd":6.56524,"marketCap":81890693200},"quantilePoints":[{"date":"2022-11-04","current":28.694216,"twenty":26.512834,"median":26.542085,"eighty":27.833364,"marketCap":25968654960},{"date":"2022-11-11","current":35.577583,"twenty":27.402937,"median":34.819032,"eighty":37.211633,"marketCap":32485133920},{"date":"2022-11-18","current":30.409033,"twenty":29.071802,"median":32.325114,"eighty":36.373143,"marketCap":27670720360},{"date":"2022-11-25","current":29.089974,"twenty":29.309257,"median":30.328688,"eighty":34.970742,"marketCap":26260437600},{"date":"2022-12-02","current":29.440115,"twenty":28.58665,"median":29.786096,"eighty":33.378719,"marketCap":27035200000},{"date":"2022-12-09","current":33.170723,"twenty":28.69893,"median":30.328688,"eighty":33.541593,"marketCap":30744000000},{"date":"2022-12-16","current":33.617702,"twenty":28.859591,"median":31.890871,"eighty":33.525219,"marketCap":31085600000},{"date":"2022-12-23","current":32.235512,"twenty":29.23003,"median":32.061881,"eighty":33.375102,"marketCap":29816800000},{"date":"2022-12-30","current":35.028223,"twenty":29.440115,"median":32.235512,"eighty":33.644993,"marketCap":32793600000},{"date":"2023-01-06","current":34.259259,"twenty":29.598569,"median":32.356077,"eighty":33.906187,"marketCap":32403200000},{"date":"2023-01-13","current":37.514633,"twenty":29.683286,"median":32.593587,"eighty":35.138095,"marketCap":36160800000},{"date":"2023-01-20","current":39.320225,"twenty":29.767789,"median":33.170723,"eighty":36.075015,"marketCap":37576000000},{"date":"2023-01-27","current":41.405428,"twenty":29.847916,"median":33.242723,"eighty":36.22764,"marketCap":39576800000},{"date":"2023-02-03","current":46.017337,"twenty":30.125824,"median":33.502098,"eighty":37.981351,"marketCap":44212800000},{"date":"2023-02-10","current":48.646066,"twenty":30.280481,"median":33.687805,"eighty":39.317619,"marketCap":46457600000},{"date":"2023-02-17","current":47.305048,"twenty":30.475064,"median":33.964048,"eighty":41.148897,"marketCap":44749600000},{"date":"2023-02-24","current":46.898265,"twenty":30.969524,"median":34.88282,"eighty":44.591745,"marketCap":43822400000},{"date":"2023-03-03","current":48.206405,"twenty":31.89643,"median":35.69024,"eighty":46.759698,"marketCap":45335200000},{"date":"2023-03-17","current":60.214956,"twenty":31.932315,"median":36.041848,"eighty":47.552658,"marketCap":56754400000},{"date":"2023-03-24","current":51.699724,"twenty":32.016899,"median":36.568073,"eighty":48.347792,"marketCap":49288000000},{"date":"2023-03-31","current":40.925047,"twenty":32.156582,"median":37.514633,"eighty":48.347792,"marketCap":46848000000},{"date":"2023-04-06","current":40.652856,"twenty":32.21578,"median":38.432644,"eighty":48.279626,"marketCap":46506400000},{"date":"2023-04-14","current":37.246115,"twenty":32.289273,"median":38.307612,"eighty":48.226605,"marketCap":42651200000},{"date":"2023-04-21","current":33.385259,"twenty":32.343692,"median":38.098031,"eighty":47.893759,"marketCap":38210400000},{"date":"2023-04-28","current":30.285025,"twenty":32.289273,"median":37.591448,"eighty":47.642868,"marketCap":34404000000},{"date":"2023-05-05","current":26.161165,"twenty":31.945964,"median":37.33158,"eighty":47.490756,"marketCap":29768000000},{"date":"2023-05-12","current":30.574645,"twenty":30.692284,"median":36.23263,"eighty":47.274687,"marketCap":34550400000},{"date":"2023-05-19","current":31.711515,"twenty":30.746535,"median":35.923479,"eighty":47.115193,"marketCap":35331200000},{"date":"2023-05-25","current":31.182824,"twenty":30.822604,"median":35.69024,"eighty":46.935066,"marketCap":34599200000},{"date":"2023-06-02","current":32.039153,"twenty":30.742861,"median":35.028223,"eighty":46.759698,"marketCap":35428800000},{"date":"2023-06-09","current":32.262222,"twenty":30.684805,"median":34.15987,"eighty":46.167812,"marketCap":35624000000},{"date":"2023-06-16","current":32.772734,"twenty":30.742861,"median":33.693297,"eighty":45.892894,"marketCap":36014400000},{"date":"2023-06-23","current":31.032471,"twenty":30.757557,"median":33.682729,"eighty":45.395124,"marketCap":33916000000},{"date":"2023-06-30","current":31.360803,"twenty":30.757557,"median":33.502098,"eighty":44.617559,"marketCap":33964800000},{"date":"2023-07-07","current":31.376956,"twenty":30.759705,"median":33.358016,"eighty":44.488487,"marketCap":33916000000},{"date":"2023-07-14","current":31.254408,"twenty":30.81937,"median":33.206723,"eighty":42.385946,"marketCap":34257600000},{"date":"2023-07-21","current":29.61115,"twenty":30.759705,"median":32.931722,"eighty":41.535665,"marketCap":32305600000},{"date":"2023-07-28","current":31.165322,"twenty":30.717545,"median":32.723027,"eighty":41.405428,"marketCap":33964800000},{"date":"2023-08-04","current":32.76763,"twenty":30.739187,"median":32.639512,"eighty":41.393979,"marketCap":35770400000},{"date":"2023-08-11","current":32.773868,"twenty":30.757557,"median":32.603384,"eighty":41.176747,"marketCap":35575200000},{"date":"2023-08-18","current":30.610294,"twenty":30.757557,"median":32.513854,"eighty":41.037499,"marketCap":32988800000},{"date":"2023-08-25","current":31.726668,"twenty":30.759705,"median":32.346784,"eighty":40.925047,"marketCap":34208800000},{"date":"2023-09-01","current":27.573424,"twenty":30.671209,"median":32.32831,"eighty":40.652856,"marketCap":36697600000},{"date":"2023-09-08","current":26.75169,"twenty":30.572064,"median":32.277824,"eighty":40.648282,"marketCap":35184800000},{"date":"2023-09-15","current":25.993592,"twenty":30.285025,"median":32.235512,"eighty":40.62978,"marketCap":34452800000},{"date":"2023-09-22","current":25.737943,"twenty":29.809068,"median":32.045764,"eighty":40.128892,"marketCap":33964800000},{"date":"2023-09-29","current":25.066298,"twenty":29.656075,"median":31.997803,"eighty":39.81665,"marketCap":33135200000},{"date":"2023-10-06","current":25.484582,"twenty":29.406098,"median":31.918666,"eighty":39.533705,"marketCap":33672000000},{"date":"2023-10-13","current":24.08012,"twenty":28.952772,"median":31.841433,"eighty":39.348774,"marketCap":31768800000},{"date":"2023-10-20","current":22.598372,"twenty":28.090884,"median":31.767659,"eighty":39.309801,"marketCap":29768000000},{"date":"2023-10-27","current":22.348635,"twenty":27.619397,"median":31.711663,"eighty":39.282609,"marketCap":29426400000},{"date":"2023-11-03","current":25.394448,"twenty":27.541831,"median":31.642548,"eighty":39.168886,"marketCap":33525600000},{"date":"2023-11-10","current":25.843419,"twenty":27.016595,"median":31.492944,"eighty":38.901953,"marketCap":34111200000},{"date":"2023-11-17","current":25.355932,"twenty":26.744612,"median":31.467436,"eighty":38.544946,"marketCap":33769600000},{"date":"2023-11-24","current":25.803053,"twenty":26.578324,"median":31.402883,"eighty":38.289787,"marketCap":34648000000},{"date":"2023-12-01","current":25.805078,"twenty":26.361375,"median":31.373452,"eighty":38.186355,"marketCap":34794400000},{"date":"2023-12-08","current":23.911147,"twenty":26.187226,"median":31.314709,"eighty":38.124793,"marketCap":32110400000},{"date":"2023-12-15","current":23.015122,"twenty":25.978956,"median":31.279712,"eighty":37.928033,"marketCap":31085600000},{"date":"2023-12-22","current":23.970526,"twenty":25.934891,"median":31.256547,"eighty":37.726838,"marketCap":32354400000},{"date":"2023-12-29","current":25.605578,"twenty":25.922833,"median":31.253927,"eighty":37.637537,"marketCap":34745600000},{"date":"2024-01-05","current":24.881987,"twenty":25.805078,"median":31.237017,"eighty":37.514633,"marketCap":33525600000},{"date":"2024-01-12","current":25.701327,"twenty":25.757517,"median":31.165322,"eighty":37.417045,"marketCap":34648000000},{"date":"2024-01-19","current":24.032983,"twenty":25.700075,"median":31.138965,"eighty":37.246115,"marketCap":32354400000},{"date":"2024-01-26","current":24.563567,"twenty":25.531167,"median":31.049171,"eighty":36.903516,"marketCap":32940000000},{"date":"2024-02-02","current":22.773078,"twenty":25.419215,"median":30.993085,"eighty":36.23263,"marketCap":30500000000},{"date":"2024-02-09","current":24.329361,"twenty":25.355932,"median":30.81937,"eighty":36.207681,"marketCap":32744800000},{"date":"2024-02-16","current":25.846624,"twenty":25.369207,"median":30.758631,"eighty":36.108181,"marketCap":34794400000},{"date":"2024-02-23","current":26.457355,"twenty":25.369207,"median":30.717545,"eighty":35.899805,"marketCap":35428800000},{"date":"2024-03-01","current":26.003824,"twenty":25.387892,"median":30.635655,"eighty":35.803782,"marketCap":34843200000},{"date":"2024-03-08","current":26.210688,"twenty":25.395134,"median":30.572064,"eighty":35.667709,"marketCap":35136000000},{"date":"2024-03-15","current":30.241869,"twenty":25.409765,"median":30.44783,"eighty":35.490153,"marketCap":40504000000},{"date":"2024-03-22","current":31.217759,"twenty":25.435494,"median":30.569793,"eighty":35.18968,"marketCap":41772800000},{"date":"2024-03-28","current":26.416103,"twenty":25.461641,"median":30.551779,"eighty":34.970062,"marketCap":41528800000},{"date":"2024-04-05","current":26.713065,"twenty":25.484582,"median":30.44783,"eighty":34.88282,"marketCap":41968000000},{"date":"2024-04-12","current":27.194611,"twenty":25.506915,"median":30.285025,"eighty":34.259259,"marketCap":42748800000},{"date":"2024-04-19","current":29.268508,"twenty":25.516475,"median":30.168532,"eighty":34.060481,"marketCap":45969600000},{"date":"2024-04-26","current":29.89571,"twenty":25.531167,"median":29.89571,"eighty":33.867614,"marketCap":46896800000},{"date":"2024-05-03","current":31.286129,"twenty":25.569811,"median":29.89571,"eighty":33.72816,"marketCap":49044000000},{"date":"2024-05-10","current":35.317002,"twenty":25.600357,"median":30.150227,"eighty":34.911901,"marketCap":51288800000},{"date":"2024-05-17","current":33.551674,"twenty":25.608792,"median":30.245106,"eighty":35.034138,"marketCap":48653600000},{"date":"2024-05-24","current":33.729665,"twenty":25.66112,"median":30.409033,"eighty":35.021714,"marketCap":48800000000},{"date":"2024-05-31","current":34.458991,"twenty":25.697876,"median":30.512617,"eighty":34.936642,"marketCap":49905929000},{"date":"2024-06-07","current":35.513458,"twenty":25.700826,"median":30.572064,"eighty":35.034138,"marketCap":51369298000},{"date":"2024-06-14","current":33.485895,"twenty":25.715973,"median":30.610294,"eighty":35.023883,"marketCap":48392099000},{"date":"2024-06-21","current":32.121521,"twenty":25.745773,"median":30.694377,"eighty":34.964455,"marketCap":46323198000},{"date":"2024-06-28","current":32.099848,"twenty":25.775731,"median":30.739187,"eighty":34.884174,"marketCap":46272737000},{"date":"2024-07-05","current":29.936022,"twenty":25.803458,"median":30.671209,"eighty":34.879736,"marketCap":43144155000},{"date":"2024-07-12","current":29.087996,"twenty":25.812746,"median":30.592469,"eighty":34.858532,"marketCap":41983552000},{"date":"2024-07-19","current":27.898783,"twenty":25.84406,"median":30.569793,"eighty":34.80307,"marketCap":40267878000},{"date":"2024-07-26","current":27.412372,"twenty":25.847354,"median":30.44783,"eighty":34.722361,"marketCap":39712807000},{"date":"2024-08-02","current":26.870727,"twenty":25.853895,"median":30.347362,"eighty":34.692602,"marketCap":38905431000},{"date":"2024-08-09","current":29.53175,"twenty":25.868681,"median":30.263126,"eighty":34.580226,"marketCap":43043233000},{"date":"2024-08-16","current":27.651468,"twenty":25.880225,"median":30.20526,"eighty":34.54918,"marketCap":40318339000},{"date":"2024-08-23","current":20.295155,"twenty":25.847354,"median":30.132576,"eighty":34.503268,"marketCap":39157736000},{"date":"2024-08-30","current":21.43279,"twenty":25.766624,"median":29.936022,"eighty":34.476088,"marketCap":41630325000},{"date":"2024-09-06","current":20.565575,"twenty":25.695677,"median":29.843348,"eighty":34.445054,"marketCap":39965112000},{"date":"2024-09-13","current":18.849184,"twenty":25.540828,"median":29.786096,"eighty":34.363297,"marketCap":36533764000},{"date":"2024-09-20","current":20.082561,"twenty":25.484582,"median":29.694562,"eighty":34.259259,"marketCap":39157736000},{"date":"2024-09-27","current":24.850231,"twenty":25.394448,"median":29.657792,"eighty":34.060481,"marketCap":48745326000},{"date":"2024-10-04","current":29.382648,"twenty":25.395362,"median":29.624666,"eighty":34.023673,"marketCap":57374157000},{"date":"2024-10-10","current":27.207172,"twenty":25.409765,"median":29.557165,"eighty":33.926357,"marketCap":52782206000},{"date":"2024-10-18","current":27.08831,"twenty":25.435494,"median":29.436062,"eighty":33.784845,"marketCap":52277596000},{"date":"2024-10-25","current":27.691447,"twenty":25.469288,"median":29.344363,"eighty":33.707844,"marketCap":53438199000},{"date":"2024-11-01","current":28.012496,"twenty":25.497982,"median":29.274876,"eighty":33.690002,"marketCap":54094192000},{"date":"2024-11-08","current":29.463901,"twenty":25.512651,"median":29.272452,"eighty":33.684759,"marketCap":56465859000},{"date":"2024-11-15","current":26.265769,"twenty":25.52529,"median":29.194481,"eighty":33.660087,"marketCap":49956390000},{"date":"2024-11-22","current":26.278217,"twenty":25.56015,"median":29.088985,"eighty":33.628618,"marketCap":49956390000},{"date":"2024-11-29","current":26.561468,"twenty":25.595136,"median":29.046664,"eighty":33.578085,"marketCap":50461000000},{"date":"2024-12-06","current":27.316407,"twenty":25.595136,"median":28.89327,"eighty":33.512207,"marketCap":51772986000},{"date":"2024-12-13","current":27.527865,"twenty":25.608792,"median":28.855293,"eighty":33.470601,"marketCap":52126213000},{"date":"2024-12-20","current":27.519045,"twenty":25.66112,"median":28.7635,"eighty":33.433798,"marketCap":51823447000},{"date":"2024-12-27","current":26.95045,"twenty":25.695677,"median":28.729978,"eighty":33.410147,"marketCap":50713305000},{"date":"2025-01-03","current":25.718533,"twenty":25.700075,"median":28.694216,"eighty":33.386493,"marketCap":48442560000},{"date":"2025-01-10","current":26.596222,"twenty":25.605578,"median":28.598093,"eighty":33.385259,"marketCap":49905929000},{"date":"2025-01-17","current":28.4557,"twenty":25.610934,"median":28.581538,"eighty":33.383573,"marketCap":53438199000},{"date":"2025-01-24","current":29.058848,"twenty":25.694577,"median":28.62658,"eighty":33.365541,"marketCap":54912816000},{"date":"2025-01-28","current":30.995109,"twenty":25.696776,"median":28.668851,"eighty":33.362531,"marketCap":58878741600},{"date":"2025-02-07","current":31.279146,"twenty":25.700576,"median":28.706002,"eighty":33.347316,"marketCap":59082122400},{"date":"2025-02-14","current":32.46032,"twenty":25.708209,"median":28.7635,"eighty":33.295849,"marketCap":61166775600},{"date":"2025-02-21","current":32.605291,"twenty":25.726297,"median":28.850334,"eighty":33.213923,"marketCap":61776918000},{"date":"2025-02-28","current":33.709306,"twenty":25.745773,"median":28.875802,"eighty":33.347316,"marketCap":63658190400},{"date":"2025-03-07","current":37.167941,"twenty":25.761386,"median":29.014465,"eighty":33.385999,"marketCap":70471447200},{"date":"2025-03-14","current":37.985438,"twenty":25.781535,"median":29.070262,"eighty":33.525362,"marketCap":72047648400},{"date":"2025-03-21","current":37.329923,"twenty":25.803863,"median":29.089974,"eighty":33.667635,"marketCap":70776518400},{"date":"2025-03-28","current":31.329348,"twenty":25.820414,"median":29.153791,"eighty":33.6911,"marketCap":69149472000},{"date":"2025-04-03","current":32.960917,"twenty":25.84406,"median":29.176551,"eighty":33.68679,"marketCap":72606945600},{"date":"2025-04-11","current":32.158951,"twenty":25.847354,"median":29.194481,"eighty":33.675182,"marketCap":70369756800},{"date":"2025-04-17","current":33.426462,"twenty":25.850275,"median":29.270028,"eighty":33.693297,"marketCap":73318778400},{"date":"2025-04-25","current":35.713683,"twenty":25.864757,"median":29.297766,"eighty":33.896985,"marketCap":78403298400},{"date":"2025-04-30","current":37.231772,"twenty":25.868985,"median":29.344363,"eighty":34.133202,"marketCap":81890693200}],"updateTime":1746201624665}}}